Anti-CEA CAR-T Cell Therapy

N/A

Report date: 2022/03/10 13:24:33

Base Information

Drug NameAnti-CEA CAR-T Cell Therapy
Drug Alias NameAnti-CEA T-cellsCAR-T-CEA-therapyCAR-T CEAAnti-CEA CAR-T
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Cell therapy > Immune system cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionAnti-CEA
TargetsCarcinoembryonic antigen
Therapy Area/IndicationsLiver NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChanghai Hospital
China Registration ClassN/A

Develop Information

Active CompaniesChanghai Hospital
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A